drugset / Trial / NCT00869115

Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure

NCT00869115 ↗

Phase 1 Withdrawn Debiopharm International SA
RandomizedQuadruple-blindTreatment

Summary

This study explores a potential drug-drug interaction between istaroxime and digoxin in patients with stable CHF on chronic oral digoxin treatment.

Timeline

Start
2009-06
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped: “The study was not started due to a re-evaluation of the istaroxime development program”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Istaroxime Small molecule 0.5 ug/kg Intravenous
Comparator Istaroxime Small molecule 1 ug/kg Intravenous
Comparator Istaroxime Small molecule 1.5 ug/kg Intravenous

Indications